B. Lecky

发表

A randomized controlled trial of recombinant interferon-beta 1a in Guillain-Barré syndrome

R. Hughes, H. Willison, A. Swan, 2003, Neurology.

Elevation of cardiac troponin T, but not cardiac troponin I, in patients with neuromuscular diseases: implications for the diagnosis of myocardial infarction.

B. Lecky, D. Rittoo, Alan E. Jones, 2014, Journal of the American College of Cardiology.

Cerebral Amyloid Angiopathy with Symptomatic or Occult Subarachnoid Haemorrhage

N. Rainov, K. Karabatsou, B. Lecky, 2006, European Neurology.

Randomized Trial of Thymectomy in Myasthenia Gravis.

A. Marx, R. Conwit, M. Benatar, 2016, The New England journal of medicine.

A randomized double‐blind trial of prednisolone alone or with azathioprine in myasthenia gravis

John Newsom-Davis, J. Palace, Jacqueline A Palace, 1998, Neurology.

Minimal manifestation status and prednisone withdrawal in the MGTX trial.

R. Conwit, M. Benatar, J. Oger, 2020, Neurology.

Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial

A. Marx, S. Muley, R. Conwit, 2019, The Lancet Neurology.

A multicenter, randomized, double-blind trial of prednisolone plus azathioprine versus prednisolone plus placebo in myasthenia gravis

J. Palace, J. Newsom-Davis, B. Lecky, 1996 .

The clinical, histochemical, and molecular spectrum of PEO1 (Twinkle)-linked adPEO

A. Seller, P. Chinnery, R. Horvath, 2010, Neurology.

Cytosolic 5′-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis

J. Lamb, C. Saris, B. V. van Engelen, 2017, Annals of the rheumatic diseases.

Cytosolic 5′-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis

J. Lamb, M. Roberts, C. Saris, 2017, Annals of the rheumatic diseases.

Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study

M. Lucchetta, D. Pareyson, A. Schenone, 2009, The Lancet Neurology.

Parkinsonism and impulse control disorder: Presentation of a new progranulin gene mutation

Sui H Wong, M. Steiger, B. Lecky, 2009, Movement disorders : official journal of the Movement Disorder Society.

Randomized Trial of Thymectomy in Myasthenia Gravis.

A. Marx, J. Davis, R. Conwit, 2017, The New England journal of medicine.

The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody–positive dermatomyositis

J. Lamb, I. Bruce, B. Harrison, 2018, Rheumatology.

WITHDRAWN: Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.

E. Choy, P. Gordon, B. Lecky, 2009, The Cochrane database of systematic reviews.

Neurophysiology of the striated urethral sphincter in multiple sclerosis.

C. Fowler, I. Eardley, R. Kirby, 1991, British journal of urology.

Novel MTND1 mutations cause isolated exercise intolerance, complex I deficiency and increased assembly factor expression

Laura C. Greaves, Robert W. Taylor, D. Turnbull, 2015, Clinical science.

Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.

E. Choy, B. Lecky, J. Winer, 2005, The Cochrane database of systematic reviews.

Statin induced myopathy

B. Lecky, S. Sathasivam, 2008, BMJ : British Medical Journal.

119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands

R. Hughes, J. Vencovský, E. Choy, 2004, Neuromuscular Disorders.

Pain intensity and distribution in chronic inflammatory demyelinating polyneuropathy

A. Goebel, B. Lecky, M. Lunn, 2012, Muscle & nerve.

X-linked and FSH dystrophies in one family

A. Read, B. Lecky, D. Wilcox, 1991, Neuromuscular Disorders.

Cortical deafness A case report and review of the literature

R. Greenwood, B. Lecky, J. Graham, 1980, Journal of the Neurological Sciences.

Distal weakness with respiratory insufficiency caused by the m.8344A > G “MERRF” mutation

Robert W. Taylor, D. Turnbull, B. Chakrabarti, 2014, Neuromuscular Disorders.

Second-line agents in myositis: 1-year factorial trial of additional immunosuppression in patients who have partially responded to steroids

D. Isenberg, K. Chakravarty, B. Griffiths, 2014, Rheumatology.

Phenotypic heterogeneity in British patients with a founder mutation in the FHL1 gene

K. Bushby, H. Lochmüller, C. Windpassinger, 2011, European Journal of Human Genetics.

Recurrent myositis triggered by infections: a case report

D. Crooks, T. Solomon, I. Hart, 2008, Journal of medical case reports.

A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group.

J. Palace, J. Newsom-Davis, B. Lecky, 1998, Neurology.

Elevation of cardiac troponin T, but not cardiac troponin I, in patients with neuromuscular diseases: implications for the diagnosis of myocardial infarction.

B. Lecky, D. Rittoo, Alan E. Jones, 2014, Journal of the American College of Cardiology.

Silhouette thread lift as an ancillary procedure in an unusual case of necrotizing myopathy of the face.

B. Lecky, A. Mishra, K. Hancock, 2011, Plastic and reconstructive surgery.

WITHDRAWN: Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.

E. Choy, P. Gordon, B. Lecky, 2009, The Cochrane database of systematic reviews.